Литература (в порядке, соответствующем упоминанию по тексту)

    1. Yanoff M., Duker J.S. Ophthalmology. – Mosby, 2004. – P. 331-335, 1152-1157.

    2. Малюгин Б.Э. Медико-технологическая система хирургической реабилитации пациентов с катарактой на основе ультра- звуковой факоэмульсификации с имплантацией интраокулярной линзы: Дис. ... д-ра мед. наук. – М., 2002. – С. 6-16, 161-234, 373.

    3. Alio J.L., Bodaghi B., Tassignon M.J. Guide- lines for managing postcataract surgery inflammation. Can we reach a consensus? // Ophthalmol. Times Europe. – 2008. – Vol. 11. – P. 2-11.

    4. Klein R., Klein B.E., Wong T.Y. et al. The association of cataract surgery with the long- term incidence of age-related maculopathy: the Beaver Dam Eye Study // Arch. Ophthalmol. – 2002. – Vol. 120. – P. 1551-1558.

    5. Cugati S., Mitchell P., Rochtchina E. et al. Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study // Ophthalmology. – 2006. – Vol. 113. – P. 2020-2025.

    6. Ho L., Boekhoorn S.S., Liana, van Duijn C.M. et al. Cataract surgery and the risk of aging macula disorder: the Rotterdam study // Invest. Ophthalmol. Vis. Sci. – 2008. – Vol. 49, No. 11. – P. 4795-4800.

    7. Chew E.Y., Sperduto R.D., Milton R.C. et al. Risk of Advanced Age-Related Macular Degeneration after Cataract Surgery in the Age-Related Eye Disease Study. AREDS Report 25 // Ophthalmology. – 2009. – Vol. 116, N 2. – P. 297-303.

    8. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 // Arch. Ophthalmol. – 2001. – Vol. 119, No. 10. – P. 1417-1436.

    9. Flach A.J. Cyclo-oxygenase inhibitors in ophthalmology // Surv. Ophthalmol. – 1992. – Vol. 36. – P. 259-284.

    10. Arshinoff S.A., Mills M., Haber S. Pharmacotherapy of photorefractive keratectomy // J. Cataract Refract. Surg. – 1996. – Vol. 22. – P. 1037-1044.

    11. Miyake K. The significance of inflammatory reactions following cataract extraction and intraocular lens implantation // J. Cataract Refract. Surg. – 1996. – Vol. 22 (Suppl.). – P. 759-763.

    12. El-Harazi S.M., Ruiz R.S., Feldman R.M. et al. Efficacy of preoperative versus postoperative ketorolac tromethamine 0,5% in reducing inflammation after cataract surgery // J. Cataract Refract. Surg. – 2000. – Vol. 26. – P. 1626-1630.

    13. Roberts C.W. Pretreatment with topical diclofenac sodium to decrease postoperative inflammation // Ophthalmology. – 1996. – Vol. 103. – P. 636-639.

    14. Donnenfeld E.D., Schrier A., Perry H.D. Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor // Ophthalmology. – 1994. – Vol. 101, No. 5. – P. 902-905.

    15. Leeming J.P., Diamond J.P., Trigg R. Ocular penetration of topical ciprofloxacin and nor- floxacin drops and their effect upon eyelid flora // Br. Ophthalmol. – 1994. – Vol. 78, No. 7. – P. 546-548.

    16. ESCRS Endophthalmitis Study Group // J. Cataract Refract. Surg. – 2007. – Vol. 33. – P. 978-988.

    17. Вохмяков А.В., Околов И.Н., Гурченок П.А. Выбор оптимального антибиотика для профилактики инфекционных осложнений в офтальмохирургии (обзор литературы) // Клиническая офтальмология. – 2007. – № 1, Т. 8. – С. 37-40.

    18. Околов И.Н., Гурченок П.А. Антибактериальные препараты в профилактике осложнений факоэмульсификации катаракты // Офтальмохирургия. – 2009. – № 1. – С. 30-32.

    19. Barry P., Cordoves L., Gardner S. ESCRS Guidelines for Prevention and Treatment of Endophthalmitis Following Cataract Surgery: Data, Dilemmas and Conclusions // The European Society for Cataract & Refractive Surgeon. – 2013.

    20. Lens and Cataract. Section 11 // Аmerican Аcademy of Оphthalmology. – 2004-2005. – P. 163-194.

    21. Bron A.M., Pechinot A.P., Garcher C.P. et al. The ocular penetration of oral spar floxacin in humans // Am. J. Ophthalmol. – 1994. – Vol. 117, No. 3. – P. 322-327.

    22. Mounier M., Ploy M.C., Chauvin M. Study of intraocular diffusion of ofloxacin in human and rabbits // Pathol. Biol. – 1992. – Vol. 40, No. 5. – P. 529-533.

    23. Marguerite B. McDonald, Esen Akpek, Peter McDonnel, Terrence P. O’Brien Risk Management Update in Infection Prophylaxis for Ocular Surgery. – 2011.

    24. Chang D.F., Braga-Mele R., Mamalis N. et al. Prophylaxis of postoperative endophthalmitis after cataract surgery; results of the 2007 ASCRS member survey; the ASCRS Cataract Clinical Committee // J. Cataract Refract. Surg. – 2007. – Vol. 33. – P. 1801-1805.

    25. Moss J.A., Nguyen D.A., Liu Y.U. et al. Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora // Ophthalmology. – 2008. – Vol. 115, No. 11. – P. 2013-2016.

    26. Chang D.F. Intracameral antibiotics. Results of 2014 ASCRS endophthalmitis antibiotic prophylaxis survey // Eye World. – 2015. – N. 1. – P. 1.

    27. Braga-Mele R., Chang D.F., Henderson B.A., Mamalis N., Talley-Rostov A., Vasavada A. Intracameral antibiotics: Safety, efficacy, and preparation // J. Cataract Refract. Surg. – 2014. – Vol. 40 (12). – P. 2134-2142.

    28. Gail Torkildsen, Joel W. Proksch, Aron Shapiro, Stephanie K. Lynch, and Timothy L. Comstock Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular aministration // Clin. Ophthalmol. – 2010. – Vol. 4. – P. 331-341.

    29. Eric Donnenfeld, Henry D. Perry, Daniel A. Chruscicki, Adam Bitterman, Stephanie Cohn and Renee Solomon.A comparison of the fourth- generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability // Curr Med Res Opin. – 2004. – Vol. 20, No. 11. – P. 1753-1758.

    30. Barry P., Seal D.V., Gettinby G., Lees F., Peterson M., Revie C.W. ESCRS Endophthalmitis Study Group. ESCRS Endophthalmitis Study Group. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study // J. Cataract Refract. Surg. – 2006. – Vol. 32, No. 3. – P. 407-410.

    31. Stephen S. Lane, Robert H. Osher, Samuel Masket, Shaleen Belani. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery // J. Cataract Refract. Surg. – 2008. – Vol. 34, No. 9. – P. 1451-1459.

    32. Wykoff C.C., Parrott M.B., Flynn H.W. Jr., Shi W., Miller D., Alfonso E.C. Nosocomial acuteonset postoperative endophthalmitis at a university teaching hospital (2002-2009) // Am J. Ophthalmol. – 2011. – Vol. 150. – P. 392-398.

    33. Romero-Aroca P., Mendez-Marin I., SalvatSerra M., Fernandez-Ballart J. et al. Results at seven years after the use of Intracameral cefazolin as an endophthalmitis prophylaxis in cataract surgery // BMC Ophthalmol. – 2012. – P. 12-22

    34. Shorstein N.H., Winthrop K.L., Herrinton L.J. Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department // J. Cataract Refract Surg. – 2013. – Vol. 39. – P. 8-14.

    35. Asbell P.A., Colby K.A., Deng S. et al. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates // Am. J. Ophthalmol. – 2008. – Vol. 145, No. 6. – P. 951-958.

    36. Recchia F.M., Busbee B.G., Pearlman R.B., Carvalho-Recchia C.A., Ho A.C. Changing trends in the microbiologic aspects of postcataract endophthalmitis // Arch. Ophthalmol. – 2005. – Vol. 123, No. 3. – P. 341-346.

    37. Deramo V.A., Lai J.C., Winokur J., Luchs J., Udell I.J. Visualoutcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureus-associated acute endophthalmitis // Am. J. Ophthalmol. – 2008. – Vol. 145, No. 3. – P. 413-417.

    38. Major J.C. Jr., Engelbert M., Flynn H.W. Jr., Miller D., Smiddy W.E., Davis J.L. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes // Am. J. Ophthalmol. – 2010. – Vol. 149, No. 2. – P. 278-283.

    39. Donnenfeld E.D., Comstock T.L., Proksch J.W. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application // J. Cataract Refract. Surg. – 2011. – Vol. 37, No. 6. – P. 1082-1089.

    40. Miller D., Flynn P.M., Scott I.U., Alfonso E.C., Flynn H.W. Jr. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates // Arch. Ophthalmol. – 2006. – Vol. 124. – P. 479-483.

    41. Mino De Kaspar H., Hoepfner A.S., Engelbert M. et al. Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model // Ophthalmology. – 2001. – Vol. 108. – P. 470-478.

    42. Cavuoto K., Zutshi D., Karp C.L. et al. Update on bacterial conjunctivitis in South Florida // Ophthalmology. – 2008. – Vol. 115. – P. 51-56.

    43. Morrissey I., Burnett R., Viljoen L., Robbins M. Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002 // J. Infect. – 2004. – Vol. 49. – P. 109-114.

    44. Flach A.J., Kraff M.C., Sanders D.R., Tanenbaum L. The quantitative effect of 0,5% ketorolactromethamine solution and 0,1% dexamethasone sodium phosphate solution on postsurgical blood-aqueousbarrier // Arch. Ophthalmol. – 1988. – Vol. 106, No. 4. – P. 408-413.

    45. Simone J.N., Pendelton R.A., Jenkins J.E. Comparison of the efficacy and safety of ketorolac tromethamine 0,5% and prednisolone acetate 1% after cataract surgery // J. Cataract Refract. Surg. – 1999. – Vol. 25. – P. 699-704.

    46. Barba K.R., Samy A., Lai C. et al. Effect of topical anti-inflammatory drugs on corneal and limbal wound healing // J. Cataract Refract. Surg. – 2000. – Vol. 26. – P. 893-897.

    47. Masket M. Comparison of the effect of topical corticosteroids and nonsteroidals on postoperative corneal astigmatism // J. Cataract Refract. Surg. – 1990. – Vol. 16, No. 6. – P. 715-718.

    48. Tranos P., Bhar G., Little B. Postoperative intraocular pressure spikes: the need to trear // Eye. – 2014. – Vol. 18. – P. 673-679.

    49. Gokhale A., Patterson E. Elevated Intraocular Pressure After Cataract Surgery. Cataract Surgery in the Glaucoma Patient. – Springer Science & Business Media, 2010. – P. 51-55.

    50. Ermis S.S., Ozturk F., Inan U.U. Comparing the effect of travoprpst and brinzolamide on intraocular pressure after phacoemulsification // Eye. – 2005. – Vol. 19. – P. 303-307.

    51. Hildebrand G.D., Wickremasinghe S.S., Tranos P.G. et al. Efficacy of anterior chamber decompression in controlling early intraocular pressure spikes after uneventful phacoemulsification // J. Cataract Refract. Surg. – 2003. – Vol. 29. – P. 1087-1092.

    52. Berson F.G., Patterson M.M., Epstein D.L. Obstruction of aqueos outflow by sodium hyaluronate in enucleated human eyes // Am. J. Ophthalmol. – 1983. – Vol. 96. – P. 668-672.

    53. Arshinoff S., Albiani D.A., Taylor-Laporte J. Intraocular pressure after bilateral cataract surgery using Healon, Healon 5, and Healon GV // J. Cataract Refract. Surg. – 2002. – Vol. 28. – P. 617-625.

    54. Zetterstrom C., Wejde G., Taube M.Healon 5: comparison of 2 removal techniques // J. Cataract Refract. Surg. – 2002. – Vol. 28. – P. 1561-1564.

    55. Holzer M.P., Tetz M.R., Auffarth G.U., Weit R., Volcker H.E.Effect of Healon 5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery // J. Cataract Refract. Surg. – 2001. – Vol. 27. – P. 213-218.

    56. Arshinoff S. Postoperative intraocular pressure spikes // J. Cataract Refract. Surg. – 2004. – Vol. 30. – P. 733-734.

    57. Shingleton B.J., Gamell L.S., O′Donoghue M.W. et al. Long-term changes in intraocular pressure after clear corneal phacoemulsification: normal patients versus glaucoma suspect and glaucoma patients // J. Cataract Refract. Surg. – 1999. – Vol. 25. – P. 885-890.

    58. Kasetti S.R., Desai S.P., Siakumar S., Sunderraj P. Preventing intraocular pressure increase after phacoemulsification and the role of perioperative apraclonidine // J. Cataract Refract. Surg. – 2002. – Vol. 28. – P. 2177-2180.

    59. Dayanir V., Ozcura F., Kir E. et al. Medical control of intraocular pressure after phacoemulsification // J. Cataract Refract. Surg. – 2005. – Vol. 31. – P. 484-488.

    60. Егоров Е.А., Егорова Т.Е. Фармакотерапия глаукомы – 2009. http://www.rlsnet.ru/ articles_451.htm.

    61. Rainer G., Menapace R., Schmetterer K. et al. Effect of dorzolamide and latanoprost on intraocular pressure after small incision cataract surgery // J. Cataract Refract. Surg. – 2002. – Vol. 28. – P. 2177-2180.

    62. Лоскутов И.А., Беляева А.В. Венозный кровоток на фоне гипотензивной терапии альфа-адреномиметиками у пациентов с первичной открытоугольной глаукомой // Глаукома. – 2012. – 2. – 25-28.

    63. Burke J., Schwartz M. Preclinical evaluation of brimonidine // Surv. Ophthalmol. – 1996. – Vol. 41, No. 1. – P. 9-18.

    64. Greenfield D.S., Liebmann J.M., Ritch R. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment // J. Glaucoma. – 1998. – Vol. 6, No. 4. – P. 250-258.

    65. Kanzow U.P.L., Bohm A.G., Katz A.B., Richard G. Scanning laser Doppler flowmetry after topical brimonidine administration (Abstract) // Invest. Ophthalmol. Vis. Sci. – 1998. – Vol. 39. – P. 271.

    66. Katsimpris J.M., Dimitrios S., Konstas A.G.P. et al. Efficacy of brimonidine 0,2% in controlling acute postoperative intraocular pressure elevation after phacoemulsification // J. Cataract Refract. Surg. – 2003. – Vol. 29. – P. 2288-2294.

    67. Cetinkaya A., Akman A., AKova Y.A.Effect of topical brinzolamide1% and brimonidine 0,2% on intraocular pressure after phacoemulsification // J. Cataract Refract. Surg. – 2004. – Vol. 30. – P. 1736-1741.

    68. Rainer G., Menapace R., Findl O. et al. Effect of topical brinzolamide 1% and brimonidine on intraocular pressure after small incision cataract surgery // J. Cataract Refract. Surg. – 2001. – Vol. 27. – P. 1227-1231.

    69. Shrivastava A. Prostaglandins, Cataract Surgery and CME // Review of ophthalmology. – 2009. – July 22.

    70. Pharmakakis N., Giannopoulos K., Stasinos S., Makri O.E., Georgakopoulos C.D. Effect of a fixed brimonidine–timolol combination on intraocular pressure after phacoemulsification // J. Cataract Refract. Surg. – 2011. – Vol. 37. – P. 279-283.

    71. Lai J.S.M., Chua J.K.H., Leung A.T.S. et al. Latanoprost versus timolol gel to prevent ocular hypertension after phacoemulsification and intraocular lens implantation // J. Cataract Refract. Surg. – 2000. – Vol. 26. – P. 386-391.

    72. Rainer G., Menapace R., Findl O. et al. Intraindividual comparison of the effect of a fixed dorzolamide-timolol combination and latanoprost on intraocular pressure after small incision cataract surgery // J. Cataract Refract. Surg. – 2001. – Vol. 27. – P. 1227-1231.

    73. Rainer G., Menapace R., Findl O. et al. Effect of a fixed dorzolamide-timolol combination on intraocular pressure after small incision cataract surgery with Viscoat // J. Cataract Refract. Surg. – 2003. – Vol. 29. – P. 1748-1752.

    74. Fry L.L. Comparison of the postoperative intraocular pressure with Betagan, Betoptic, Timoptic, Iopidine, Diamox, Pilopine Gel, and Miostat // J. Cataract Refract. Surg. – 1992. – Vol. 18. – P. 14-19.

    75. Ruiz R.S., Rhem M.N., Prager T.C. Effects of carbachol and acetilcholine on intraocular pressure after cataract extraction // Am. J. Ophthalmol. – 1989. – Vol. 107. – P. 7-10.

    76. Forster R.K. Endophthalmitis // Duane’s Clinical Ophthalmology on CD-ROM / Ed. by W. Tasman, E.A. Jaeger. – Lippincott, Williams & Wilkins, 2005. – Vol. 4. – Ch. 24.

    77. Star M.B., Lally J.M. Antimicrobial prophylaxis for ophthalmic surgery // Surv. Ophthalmol. – 1995. – Vol. 39, No. 6. – P. 485-501.

    78. ESCRS Guidelines on prevention, investi- gation and management of post-operative endophthalmitis. Version 2 // The European Society for Cataract & Refractive Surgeon. – 2007. – P. 1-5, 8-14, 22-23.

    79. Кански Джек Дж. Клиническая офтальмология. Систематизированный подход. – М.: Логосфера, 2006. – С. 174-180.

    80. Endophthalmitis Vitrectomy Study Group: Results of the endophthalmitis vitrectomy study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis // Arch. Ophthalmol. – 1995. – Vol. 113. – P. 1479-1496.

    81. Yanoff M., Duker J.S. Ophthalmology. 3rd ed. / Ed. by M. Yanoff, J.S. Duker. – Mosby, 2008. – P. 1552.

    82. Егоров Е.А., Астахов Ю.С., Ставицкая Т.В. Офтальмофармакология. 3-е изд. – М.: Геотар-Медиа, 2009. – С. 120-122.

    83. Регистр лекарственных средств России РЛС. Энциклопедия лекарств. Вып. 16 / Гл. ред. Г.Л. Вышковский. – М.: РЛС-2008, 2007. – С. 1456. http://www.rlsnet.ru/fg_ index_id_253.htm; http://www.rlsnet.ru/ fg_index_id_261.htm.

    84. Monson M.C., Mamalis N., Olson R.J. Toxic anterior segment inflammation following cataract surgery // J. Cataract Refract. Surg. – 1992. – Vol. 18. – P. 184-189.

    85. Mamalis N., Edelhauser H.F., Dawson D.G. et al. Toxic anterior segment syndrome // J. Cataract Refract. Surg. – 2006. – Vol. 32. – P. 324-333.

    86. Meltzer D.W. Sterile hypopyon following intraocular lens surgery // Arch Ophthalmol. – 1980. – Vol. 98. – P. 100-104.

    87. Worst J.G.F. A retrospective view on the sterilization of intraocular lenses and incidents of sterile hypopyone // Am. Intraocular Implant Soc. J. – 1980. – Vol. 6. – P. 10-12.

    88. Albert & Jakobiec’s Principles and Practice of Ophthalmology. – Elsevier, 2008. – 3rd ed. – Vol. 1. – 1638 pp.

    89. Coscas G. (ed.). Macular Edema: A Practical Approach. – Basel: Karger, 2010. – 215 pp.

    90. Шпак А.А., Малюгин Б.Э., Фадеева Т.В. Влияние желтого светофильтра ИОЛ на состояние макулярной зоны после фако- эмульсификации катаракты у пациентов с возрастной макулярной дегенерацией // Вестн. офтальмол. – 2012. – № 4. – С. 48-51.

    91. Шпак А.А., Лоскутов И.А. Простагландиновые препараты в лечении глаукомы (Обзор литературы) // Офтальмохирургия. – 2000. – № 1. – С. 47-53.

    92. Jaffe N.S. Cataract surgery and its complications. – St. Louis: Mosby, 1984. – P. 426-441.

    93. Yanuzzi L.A., Klein R.M., Wallyn R.H. et al. Ineffectiveness of indomethacin in the treatment of chronic cyctoid macular edema // Am. J. Ophthalmol. – 1977. – Vol. 84. – P. 517-519.

    94. Miyake K., Masuda K., Shirato S. et al. Comparison of diclofenac and fluorometholone in preventing cyctoid macular edema after small incision cataract surgery: a multicentred prospective trial // Jpn. J. Ophthalmol. – 2000. – Vol. 44. – P. 58-67.

    95. Rossetti L., Bujtar E., Castoldi D. et al. Effectiveness of diclofenac eye drops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery // J. Cataract Refract. Surg. – 1996. – Vol. 22 (Suppl.). – P. 794-799.

    96. Heier J.S., Topping T.M., Baumann W. et al. Ketorolac versus prednisilone versus combination therapy in the treatment of acute pseudophakic cyctoid macular edema // Ophthalmology. – 2000. – Vol. 107. – P. 2034-2039.

    97. Freeman E., Munoz B., West S. et al. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies // Am. J. Ophthalmol. – 2003. – Vol. 135. – P. 849-856.

    98. Cugati S., Mitchell P., Rochtchina E. et al. Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study // Ophthalmology. – 2006. – Vol. 113, No. 11. – P. 2020-2025.

    99. Klein B.E., Howard K.P., Lee K.E. et al. The relationship of cataract and cataract extraction to age-related macular degeneration: the Beaver Dam Eye Study // Ophthalmology. – 2012. – Vol. 119, No. 8. – P. 1628-1633.

    100. Baatz Н., Darawsha R., Ackermann H. et al. Phacoemulsification does not induce neovascular age-related macular degeneration // Invest. Ophthalmol. Vis. Sci. – 2008. – Vol. 49. – P. 1079-1083.

    101. Chew E.Y., Sperduto R.D., Milton R.C. et al. Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25 // Ophthalmology. – 2009. – Vol. 116, No. 2. – P. 297-303.

    102. Xu L., You Q.S., Cui T., Jonas J.B. Association between asymmetry in cataract and asymmetry in age-related macular degeneration. The Beijing Eye Study // Graefes Arch. Clin. Exp. Ophthalmol. – 2011. – Vol. 249, No. 7. – P. 981-985.

    103. Tabandeh H., Chaudhry N.A., Boyer D.S. et al. Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy // J. Cataract Refract. Surg. – 2012. – Vol. 38, No. 4. – P. 677-682.

    104. Muzyka-Wozniak M. Phacoemulsification in eyes with neovascular AMD treated with antiVEGF injections // Eur. J. Ophthalmol. – 2011. – Vol. 21, No. 6. – P. 766-770.

    105. Chatterjee S., Savant V.V., Stavrou P. Diabetic retinopathy progression and visual outcome after phacoemulsification in South-Asian and Afro-Caribbean patients with diabetes // Eye. – 2004. – Vol. 18, No. 6. – P. 575-579.

    106. Romero-Aroca P., Fernandez-Ballart J., Almena-Garcia M. et al. Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study // J. Cataract Refract. Surg. – 2006. – Vol. 32, No. 9. – P. 1438-1444.

    107. Suto C., Hori S., Kato S. Management of type 2 diabetics requiring panretinal photocoagulation and cataract surgery // J. Cataract Refract. Surg. – 2008. – Vol. 34, No. 6. – P. 1001-1006.

    108. Browning D.J. (ed.). Diabetic retinopathy. – N.Y. etc.: Springer, 2010. – 454 p.

    109. Oshima Y., Sakaguchi H., Gomi F., Tano Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy // Am. J. Ophthalmol. – 2006. – Vol. 142, No. 1. – P. 155-158.

    110. Chew E.Y., Benson W.E., Remaley N.A. et al. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25 // Arch. Ophthalmol. – 1999. – Vol. 117, No. 12. – P. 1600-1606.

    111. Squirrell D., Bhola R., Bush J. et al. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes // Br. J. Ophthalmol. – 2002. – Vol. 86, No. 5. – P. 565-571.

    112. Friedman D.S., Jampel H.D., Lubomski L.H., Kempen J.H., Quigley H., Congdon N., Verbin H.L., Robinson K.A., Bass E.B. Surgical Strategies for Coexisting Glaucoma and Cataract // Ophthalmology. – 2002. – Vol. 109. – P. 1902-1913.

    113. Hylton C., Robin A. Update on Prostaglandin Analogs // Current Opinion in Ophthalmology. – 2003. – Vol. 14. – P. 65-69.

    114. Van der Valk R., Webers C.A.B., Schouten J.S.A.G. et al. Intraocular pressure-lowering effects of all commonly used glaucoma drugs // Ophthalmology. – 2005. – Vol. 112. – P. 1177-1185.

    115. Ayyala R.S. et al. Cystoid Macular Edema associated with latanoprost in aphakic and pseudophakic eyes // Am. J. Ophthalmol. – 1998. – Vol. 126. – P. 602-604.

    116. Yeh P., Ramanathan S. Latanoprost and clinically significant cystoid macular edema after uneventful phacoemulsification with intraocular lens implantation // J. Cataract Refract. Surg. – 2002. – Vol. 28, No. 10. – P. 1814-1818.

    117. Schumer R.A., Camras C.B., Mandahl A.K. Latanoprost and cystoid macular edema: Is there a causal relation? // Curr Opinion in Ophthalmology. – 2000. – Vol. 11. – P. 94-100.

    118. Henderson B.A. et al. Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment // J. Cataract Refract. Surg. – 2008. – Vol. 34, No. 5. – P. 717-718.

    119. Nguyen Q. The role of prostaglandin analogues in the treatment of glaucoma in the 21st century // Int. Ophthalmol. Clin. – 2004. – Vol. 44, No. 2. – P. 15-27.

    120. Miyake K. et al. ESCRS Binkhorst lecture 2002: Pseudophakic preservative maculopathy // J. Cataract Refract. Surg. – 2003. – Vol. 29, No. 9. – P. 1800-1810.

    121. Kahook M., Noecker R.J. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with BAK, and PF artificial tears // Cornea. – 2008. – Vol. 27. – P. 339-343.

    122. Asano S. et al. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1% // J. Cataract Refract. Surg. – 2008. – Vol. 34, No. 1. – P. 57-63.

    123. Федоров С.Н., Егорова Э.В. Ошибки и осложнения при имплантации искусственного хрусталика. – М., 1992. – С. 32-40, 166-182.

    124. Тахчиди Х.П., Егорова Э.В., Толчинская А.И. Интраокулярная коррекция в хирургии осложненных катаракт. – М.: Издво «Новое в медицине», 2007. – 176 с